Mesoporous silicon particles for the presentation of tumor antigens and adjuvant for anti-cancer immunity
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 6, 2015
Issued Date -
N/A
app pub date -
Dec 7, 2012
filing date -
Dec 7, 2011
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Disclosed are mesoporous silicon multi-stage vehicles that comprise liposomal-based second-stage particles, as well as pharmaceutical compositions and formulations including such vectors for use in a variety of diagnostic and therapeutic indications. In particular embodiments, MSV comprising ligand decorated second-stage particles are provided for therapeutic methods including, for example, treatment of mammalian cancers, including those of the human breast.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully